Competitive Intelligence Blogs

Insights, analysis, and strategies focused on Competitive Intelligence.

Know more about our Pharmaceutical Competitive Intelligence Services
Also checkout our Pharmaceutical Strategic Insights

Radioligand Therapy (RLT) in 2025: The New Billion-Dollar Frontier in Oncology

The radioligand therapy market is growing rapidly, driven by rising cancer cases, advances in nuclear medicine, and targeted therapies using radioisotopes like Lutetium-177 and Actinium-225.

January 29, 2026

From Immunoglobulins to FcRn Inhibitors: Revolutionizing Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Care

September 15, 2025

Breaking the T-Cell Barrier: How Cell Therapies Are Reshaping T-Cell Lymphoma Treatment

September 15, 2025

Hepatocellular Carcinoma (HCC): Innovation, Rivalry, and the Future of Liver Cancer Therapies

May 7, 2025

Strategic Overview of Hemophilia B Therapies: From Recombinant Factors to Gene Technologies

May 5, 2025

Rewriting the Fabry Disease Story: From Lifelong Infusions to One-Time Therapies

April 30, 2025